AI for Pharmaceutical Market

  • Published on 2025-11-11
  • Report Code: 424
  • 170-350 pages
AI for Pharmaceutical Market

AI for Pharmaceutical Market Segmentation: By Product Type (Software, Services and Hardware); By Technology (Deep Learning, Querying MethodNatural Language Processing and Context aware Processing); By Application (Drug Discovery &Repurposing (Preclinical Phase), Clinical Research Trial, Personalized Medicine and Others); and Region - Analysis of Market Size, Share & Trends for 2018 - 2020 and Forecasts to 2030

Table Of Content

Contents        

  1. Executive Summary
  2. AI In Pharmaceutical
    1. AI in Pharmaceutical Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  6. Recent Development, Policies & Regulatory Landscape
  7. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  8. AI in Pharmaceutical Industry Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  9. Global AI in Pharmaceutical Market
    1. Market Size & forecast, 2019A-2030F
      1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    2. Global AI in Pharmaceutical Market: Market Segmentation
      1. By Regions
        1. North America: (U.S. and Canada)
          • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
        2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
          • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
        3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
          • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
        4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
          • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
        5. the Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
          • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. By Product Type: Market Share (2020-2030F)
        1. Software, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
        2. Services, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
        3. Hardware, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. By Applications: Market Share (2020-2030F)
        1. Drug Discovery & Repurposing, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
        2. Clinical Research Trial, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
        3. Personalized Medicine, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
        4. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. By Technology: Market Share (2020-2030F)
        1. Deep Learning, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
        2. Querying Method, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
        3. Natural Language Processing, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
        4. Context-aware Processing, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 
  10. Company Profile
  11. IBM Corporation
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  12. Microsoft
  13. Google
  14. GNS Healthcare
  15. Benevolent AI
  16. IBM
  17. InSilico Medicine Inc.
  18. Globavir Biosciences Inc.
  19. Cloud Pharmaceuticals
  20. Verge Genomics
  21. Recursion Pharmaceuticals,
  22. Flatiron HealthBenevolentAI Ltd
  23. F. Hoffmann La-Roche AG
  24. Merck KGaA

Consultant Recommendation

The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients